Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada. As of October 27, 2023, Mindset Pharma Inc. operates as a subsidiary of Otsuka America, Inc.